Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Branched DNA technology in molecular diagnostics.

Gregory J Tsongalis1

  • 1Department of Pathology, Dartmouth Medical School, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA.

American Journal of Clinical Pathology
|August 2, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel adomavirus from proliferative skin lesions of a broadnose sevengill shark (Notorynchus cepedianus).

Npj viruses·2026
Same author

On the Progression From Early-to Late-Stage Melanoma: A Potential Sequence of Molecular Events Using Data From Droplet Digital PCR and Array Comparative Genomic Hybridization, A Pilot Study.

The American Journal of dermatopathology·2026
Same author

Development of a multiplex ddPCR assay for simultaneous absolute quantification of bacterial, fungal, and human DNA.

PloS one·2026
Same author

Germline Cancer Predisposition Results From the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.

JCO precision oncology·2025
Same author

Standardized Workflow and Analytical Validation of Cell-Free DNA Extraction for Liquid Biopsy Using a Magnetic Bead-Based Cartridge System.

Cells·2025
Same author

Novel Homozygous Full Gene Deletion of SLC12A5 in a Newborn With Refractory Seizures.

American journal of medical genetics. Part A·2025

Branched DNA (bDNA) assays are FDA-approved for HIV-1 and hepatitis C virus (HCV) viral load testing. This technology offers automated, labor-saving viral quantification for routine patient management.

Area of Science:

  • Clinical Virology
  • Molecular Diagnostics
  • Biotechnology

Background:

  • Viral load testing is crucial for managing HIV-1 and HCV infections.
  • Several molecular technologies exist for viral quantification in clinical labs.

Purpose of the Study:

  • To provide a historical perspective on branched DNA (bDNA) assays.
  • To discuss the clinical applications of bDNA technology for viral load testing.

Main Methods:

  • Focuses on branched DNA (bDNA) signal amplification technology.
  • Highlights hybridization reactions and their suitability for automation.

Main Results:

  • bDNA assays are the only FDA-approved methods for HIV-1 and HCV viral load testing.

Related Experiment Videos

  • The technology is highly amenable to full automation, reducing labor.
  • Conclusions:

    • bDNA assays are a key tool in the routine management of HIV-1 and HCV patients.
    • Automation of bDNA technology enhances efficiency in clinical laboratories.